Elpis Biopharma signs MoU with NCCS to conduct translational cell therapy research in Singapore

US-based startup Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T the...

July 28, 2025 | Monday | News
New Australian collaboration to advance gene and cell therapy sector

Australia-based contract development and manufacturing organisations Viral Vector Manufacturing Facility (VVMF) and...

July 22, 2025 | Tuesday | News
NKGen Biotech and HekaBio enter strategic partnership to bring novel NK cell therapy to Japan

US-headquartered NKGen Biotech, Inc. a clinical-stage biotechnology company focused on the development and commerci...

July 21, 2025 | Monday | News
Abu Dhabi plans to advance gene therapies for children with Spinal Muscular Atrophy Type 1

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...

July 7, 2025 | Monday | News
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge

Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...

July 2, 2025 | Wednesday | Opinion
“APAC is dynamic and rapidly evolving, with tremendous growth in R&D and attractive market conditions”

What are the current developments taking place at CTMC, and what are your major plans for the next five years?  CT...

July 1, 2025 | Tuesday | Opinion
AGC Biologics expands cell therapy development operations to Asia

AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC...

June 26, 2025 | Thursday | News
EVA Pharma and Porton Advanced Solutions to expand CAR T-cell therapy access in Middle East and Africa

EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East ...

June 26, 2025 | Thursday | News
Xcell Biosciences collaborates with Thermo Fisher to advance next generation of cell therapies

Xcell Biosciences, a San Francisco-based instrumentation company focused on cell and gene therapy applications, has anno...

June 25, 2025 | Wednesday | News
Saudi Arabia to open first fully integrated, modular advanced therapy medicinal product manufacturing campus

At the BIO International Convention 2025 in Boston, King Faisal Specialist Hospital & Research Centre (KFS...

June 18, 2025 | Wednesday | News
US-Singapore collaboration to develop next generation allogeneic CAR technologies

US-based startup Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-...

June 4, 2025 | Wednesday | News
Milestone partnership highlighting Korea’s expanding influence in global biotech innovation

MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...

June 3, 2025 | Tuesday | News
PlasmidFactory: Pioneering Minicircle DNA for Safer and More Efficient Gene Therapies

As the field shifts toward safer and more efficient gene delivery methods, PlasmidFactory’s proprietary technology...

June 1, 2025 | Sunday | News
Japan establishes first next-gen commercial production site for CAR-T cell therapies

Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...

May 30, 2025 | Friday | News
Alloy Therapeutics enters Japanese market by establishing operations at Shonan Health Innovation Park

Alloy Therapeutics Inc., a US-based biotechnology ecosystem company, has recently opened its first location in Japa...

May 23, 2025 | Friday | News
US-Saudi Arabi partnership to advance T regulatory cell therapies for unmet diseases

King Faisal Specialist Hospital & Research Centre (KFSHRC) and Cellenkos Inc., a Texas based clinical stage bio...

May 22, 2025 | Thursday | News
Thermo Fisher opens Cell and Gene Therapy Vision Centre in South Korea

Thermo Fisher recently celebrated the opening of its new Cell and Gene Therapy (CGT) Vision Centre in South Korea. The c...

May 17, 2025 | Saturday | News
Japan approves Sarepta's gene therapy to treat Duchenne Muscular Dystrophy

US-based Sarepta Therapeutics, Inc. has announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has a...

May 14, 2025 | Wednesday | News